<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6818521\results\search\disease\results.xml">
  <result pre="and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.bjsports-2018-100487.pdf Abstract Objectives The" exact="common cold" post="is the main cause of medical time loss in"/>
  <result pre="(POCT). Methods We performed a prospective observational study of the" exact="common cold" post="in Team Finland during the 2018 Winter Olympic Games."/>
  <result pre="staff members. The chief physician recorded the symptoms of the" exact="common cold" post="daily on a standardised form. Two nasal swabs were"/>
  <result pre="45 min using a molecular POCT for respiratory syncytial virus and" exact="influenza" post="A and B viruses. After the Games, the other"/>
  <result pre="out of 68 (32%) staff members experienced symptoms of the" exact="common cold" post="during a median stay of 21 days. Eleven (26%)"/>
  <result pre="Eleven (26%) samples tested virus-positive using POCT. All subjects with" exact="influenza" post="(n=6) and 32 close contacts were treated with oseltamivir."/>
  <result pre="close contacts were treated with oseltamivir. The aetiology of the" exact="common cold" post="was finally detected in 75% of the athletes and"/>
  <result pre="identified. They were caused by coronaviruses 229E, NL63 and OC43," exact="influenza" post="B virus, respiratory syncytial virus A, rhinovirus and human"/>
  <result pre="be clinically valuable, especially for influenza. The aetiology of the" exact="common cold" post="was identified in most cases. athlete infection respiratory olympics"/>
  <result pre="Ane Gyllenbergin Säätiö Introduction Elite athletes are predisposed to the" exact="common cold" post="due to heavy physical and mental stress which may"/>
  <result pre="its timing coincides with epidemics of many respiratory viruses. The" exact="common cold" post="has been said to be ‘the most dreaded opponent’"/>
  <result pre="and may ruin the athlete’s long-term goal of success.7 The" exact="common cold" post="is a prevalent, complex and heterogeneous illness.8 More than"/>
  <result pre="study was to investigate the occurrence and aetiology of the" exact="common cold" post="in Team Finland during the 2018 Winter Olympic Games."/>
  <result pre="Olympic Games. We used recently developed molecular multiplexed POCT for" exact="influenza" post="A and B viruses and respiratory syncytial virus at"/>
  <result pre="+8°C and between 12% and 77%, respectively. Monitoring of the" exact="common cold" post="was provided to Team Finland members who stayed in"/>
  <result pre="also taken from subjects exposed to a patient with the" exact="common cold." post="Specimens for POCT were collected as part of the"/>
  <result pre="provisions of the Declaration of Helsinki. Assessment of illness The" exact="common cold" post="was defined as the acute onset of any of"/>
  <result pre="instructions to detect respiratory syncytial virus A and B, adenovirus," exact="influenza" post="A and B viruses, rhinovirus, parainfluenza type 1–4 viruses,"/>
  <result pre="pneumoniae and Mycoplasma pneumoniae. A laboratory-designed triplex RT-PCR assay for" exact="influenza" post="A, A/H1pdm09 and B viruses was performed as described"/>
  <result pre="and 95% CIs were calculated accordingly. Results Occurrence of the" exact="common cold" post="Forty-two out of 112 team members reported symptoms of"/>
  <result pre="A and B. Figure 2 Occurrence and aetiology of the" exact="common cold." post="The figure shows the departure day (D) from Helsinki"/>
  <result pre="day (A) to Helsinki of each subject who got the" exact="common cold" post="during the Games. The coloured bars represent different viruses"/>
  <result pre="virus A; RSV B, respiratory syncytial virus B; Inf B," exact="influenza" post="B virus; Inf A, influenza A virus; MPV, human"/>
  <result pre="syncytial virus B; Inf B, influenza B virus; Inf A," exact="influenza" post="A virus; MPV, human metapneumovirus; RV, rhinovirus; 229E, human"/>
  <result pre="human coronavirus OC43; NL63, human coronavirus NL63. Aetiology of the" exact="common cold" post="detected by molecular POCT Onsite, the aetiology of respiratory"/>
  <result pre="42 (26%) symptomatic cases. Before the Games, two cases of" exact="influenza" post="B were detected by local healthcare services using antigen"/>
  <result pre="POCT in the team’s medical room detected one case of" exact="influenza" post="A virus, three cases of influenza B virus and"/>
  <result pre="detected one case of influenza A virus, three cases of" exact="influenza" post="B virus and five cases of respiratory syncytial virus"/>
  <result pre="cases of respiratory syncytial virus A. The aetiology of the" exact="common cold" post="was identified in six athletes and in five staff"/>
  <result pre="and in five staff members. All six patients with an" exact="influenza" post="virus infection were treated with oseltamivir. Oseltamivir prophylaxis was"/>
  <result pre="None of them developed a symptomatic infection. Aetiology of the" exact="common cold" post="detected by multiplex-PCR-testing in the laboratory The aetiology of"/>
  <result pre="detected by multiplex-PCR-testing in the laboratory The aetiology of the" exact="common cold" post="was finally detected in 30 of 42 patients, in"/>
  <result pre="the laboratory. Four athletes competed with mild symptoms of the" exact="common cold." post="One athlete competed 5 days after the onset of"/>
  <result pre="One athlete competed 5 days after the onset of an" exact="influenza" post="B infection, another competed 5 days after the onset"/>
  <result pre="after the onset of a metapneumovirus infection. Transmission of the" exact="common cold" post="within the team One subject reported nasal congestion when"/>
  <result pre="respiratory syncytial virus A detection. One subject developed a febrile" exact="influenza" post="B infection during the 9-hour outbound flight. Another subject"/>
  <result pre="on the same flight (seated one row behind) developed an" exact="influenza" post="B infection 1.5 days later. Three more subjects were"/>
  <result pre="1.5 days later. Three more subjects were infected with the" exact="influenza" post="B virus. These cases were separate and were not"/>
  <result pre="one asymptomatic subject staying outside the village was predisposed to" exact="influenza" post="B infection. In both cases, rhinovirus infection was later"/>
  <result pre="Rhinovirus 1 – –  Ski jumping 6 3 Metapneumovirus 2," exact="influenza" post="A 1 – – Staff members  Coaches 18 6"/>
  <result pre="1 Rhinovirus 1  Physiotherapists 5 3 Coronavirus 229E+coronavirus NL63 1," exact="influenza" post="B 1 1 –  Masseuses 4 1 Negative 2"/>
  <result pre="of the staff members suffered from the symptoms of the" exact="common cold" post="during the median stay of 3 weeks at the"/>
  <result pre="Winter Olympic Games. Second, POCT multiplex PCR diagnostics rapidly detected" exact="influenza" post="A and B virus, and respiratory syncytial virus infections."/>
  <result pre="respiratory syncytial virus infections. Third, the probable aetiology of the" exact="common cold" post="could be detected in 75% of the athletes and"/>
  <result pre="respiratory viruses were found within the team. Occurrence of the" exact="common cold" post="during the winter games Two previous studies by the"/>
  <result pre="physician informed all team members about the monitoring of the" exact="common cold." post="She stayed in the same building as the team"/>
  <result pre="days immediately after the Tour de Ski.23 Aetiology of the" exact="common cold" post="in elite athletes Our study is the first to"/>
  <result pre="Diagnostics had clinical implications in the treatment and prevention of" exact="influenza" post="A and B infections. In addition to early treatment"/>
  <result pre="causative virus in 75% of the elite athletes with the" exact="common cold." post="Causality is supported by a 4%–6% occurrence of respiratory"/>
  <result pre="the staff (table 1). Before and during the Winter Games," exact="influenza" post="and respiratory syncytial virus epidemics were occurring in Finland"/>
  <result pre="and respiratory syncytial virus epidemics were occurring in Finland and" exact="influenza" post="and coronavirus epidemics were under way in South Korea."/>
  <result pre="contributed to the transmission of the infections. Transmission of the" exact="common cold" post="In three subjects, the symptoms of the common cold—one"/>
  <result pre="three subjects, the symptoms of the common cold—one caused by" exact="influenza" post="B virus and the others by respiratory syncytial virus"/>
  <result pre="factor for the transmission of contagious diseases. One person with" exact="influenza" post="can transmit the infection to 5–10 people during an"/>
  <result pre="and clinical significance of asymptomatic infections (eg, most coronavirus and" exact="influenza" post="infections are asymptomatic) and prolonged virus shedding (ie, infectiousness)"/>
  <result pre="The POCT diagnostics detected only three respiratory viruses.16 The 2018" exact="influenza" post="and respiratory syncytial virus epidemics were prominent, which may"/>
  <result pre="Molecular POCT diagnostics proved clinically valuable. The aetiology of the" exact="common cold" post="was identified in the majority of cases. The viruses"/>
  <result pre="athletes and 32% of the support staff suffered from the" exact="common cold" post="during a median observation period of 21 days. We"/>
  <result pre="used a fast and automated molecular point-of-care test (POCT) for" exact="influenza" post="A and B viruses and respiratory syncytial virus on"/>
  <result pre="in 11 of 42 (26%) symptomatic cases. All subjects with" exact="influenza" post="and close contact with individuals with influenza were treated"/>
  <result pre="All subjects with influenza and close contact with individuals with" exact="influenza" post="were treated with oseltamivir. In the laboratory the aetiology"/>
  <result pre="treated with oseltamivir. In the laboratory the aetiology of the" exact="common cold" post="was detected in 75% of the elite athletes. These"/>
  <result pre="enhance timely isolation to decrease viral transmission. The incidence of" exact="influenza" post="virus infection reinforces the need for influenza vaccination in"/>
  <result pre="The incidence of influenza virus infection reinforces the need for" exact="influenza" post="vaccination in sport teams. At major sport events, healthcare"/>
  <result pre="New York TimesThe most dreaded opponent at the Olympics: the" exact="common cold," post="2018 Available: https://www.nytimes.com/2018/02/11/sports/olympics/common-cold-athletes.html 8HeikkinenT, JärvinenAThe common cold. Lancet2003;361:51–9. 10.1016/S0140-6736(03)12162-912517470"/>
  <result pre="the Olympics: the common cold, 2018 Available: https://www.nytimes.com/2018/02/11/sports/olympics/common-cold-athletes.html 8HeikkinenT, JärvinenAThe" exact="common cold." post="Lancet2003;361:51–9. 10.1016/S0140-6736(03)12162-912517470 9MäkeläMJ, PuhakkaT, RuuskanenO, et al.Viruses and bacteria"/>
  <result pre="RuuskanenO, et al.Viruses and bacteria in the etiology of the" exact="common cold." post="J Clin Microbiol1998;36:539–42.9466772 10van BeekJ, VeenhovenRH, BruinJP, et al.Influenza-like"/>
  <result pre="VeenhovenRH, BruinJP, et al.Influenza-like illness incidence is not reduced by" exact="influenza" post="vaccination in a cohort of older adults, despite effectively"/>
  <result pre="in a cohort of older adults, despite effectively reducing laboratory-confirmed" exact="influenza" post="virus infections. J Infect Dis2017;216:415–24. 10.1093/infdis/jix26828931240 11ByingtonCL, AmpofoK, StockmannC,"/>
  <result pre="literature review. Rev Med Virol2018;28:e199710.1002/rmv.199730043515 13LauMSY, CowlingBJ, CookAR, et al.Inferring" exact="influenza" post="dynamics and control in households. Proc Natl Acad Sci"/>
  <result pre="Med2017;5:401–11. 10.1016/S2213-2600(17)30120-028392237 16CohenDM, KlineJ, MayLS, et al.Accurate PCR detection of" exact="influenza" post="A/B and respiratory syncytial viruses by use of Cepheid"/>
  <result pre="10.1016/S0091-6749(98)70301-X9648698 18JokelaP, VuorinenT, WarisM, et al.Performance of the Alere i" exact="influenza" post="A&amp;amp;B assay and mariPOC test for the rapid detection"/>
  <result pre="A&amp;amp;B assay and mariPOC test for the rapid detection of" exact="influenza" post="A and B viruses. J Clin Virol2015;70:72–6. 10.1016/j.jcv.2015.07.29426305824 19OsterbackR,"/>
  <result pre="et al.Viral shedding and transmission potential of asymptomatic and paucisymptomatic" exact="influenza" post="virus infections in the community. Clin Infect Dis2017;64:736–42. 10.1093/cid/ciw84128011603"/>
  <result pre="intervention study on higher-dose oseltamivir treatment in adults hospitalized with" exact="influenza" post="A and B infections. Clin Infect Dis2013;57:1511–9. 10.1093/cid/cit59724046309 25LeeN,"/>
  <result pre="Dis2013;57:1511–9. 10.1093/cid/cit59724046309 25LeeN, ChanMCW, LuiGCY, et al.High viral load and" exact="respiratory failure" post="in adults hospitalized for respiratory syncytial virus infections. J"/>
  <result pre="al.Serology enhances molecular diagnosis of respiratory virus infections other than" exact="influenza" post="in children and adults hospitalized with community-acquired pneumonia. J"/>
  <result pre="with community-acquired pneumonia. J Clin Microbiol2017;55:79–89. 10.1128/JCM.01701-1627795341 33LeitmeyerK, AdlhochCReview article:" exact="influenza" post="transmission on aircraft: a systematic literature review. Epidemiology2016;27:743–51. 10.1097/EDE.000000000000043827253070"/>
  <result pre="PantelicJ, et al.Infectious virus in exhaled breath of symptomatic seasonal" exact="influenza" post="cases from a College Community. Proc Natl Acad Sci"/>
 </snippets>
</snippetsTree>
